Lab marker

IGF-1

Insulin-like growth factor 1 · Somatomedin C

A growth-hormone-axis proxy with a U-shaped mortality relationship: both very high and very low values associate with elevated risk.

Moderate relevance4 cited sourcesNo fasting€30–60 private.nutritionmovement

What it measures

Insulin-like growth factor 1, primarily hepatic-derived under growth hormone stimulation. Captures integrated GH-axis activity over hours-to-days. Reported in ng/mL or nmol/L. Strongly age-dependent; declines from peak in adolescence through old age.

Reference context

2 guideline sources

IGF-1 declines roughly 1–2% per year through adulthood. Very high values may suggest acromegaly; very low values in a symptomatic adult may suggest GH deficiency. Mid-normal-for-age values appear lowest-mortality in most cohort meta-analyses.

Population context: consult guideline targets below

Mechanism

Why moving this marker matters

IGF-1 mediates many of GH's anabolic effects on tissues: muscle, bone, organs. The longevity literature presents an apparent paradox: very low IGF-1 (Laron syndrome, calorie restriction) is associated with reduced cancer incidence and extended lifespan in animal models, while in humans, both very low and very high IGF-1 are associated with elevated mortality (U-shaped relationship; Burgers 2011 meta-analysis, Rahmani 2022 meta-analysis).

Guideline targets

What major guidelines recommend

Age- and sex-adjusted reference (lab-specific)

Moderate

Most labs report results as z-score or % of age-matched reference. Track against percentile rather than absolute value.

Approximate adult reference (lab-dependent)

Moderate

Ages 30–40: ~120–260 ng/mL; 40–60: ~80–230 ng/mL; 60+: ~60–200 ng/mL

How to measure

The test, where to get it, when to repeat

Method

Standard blood draw. Time of day modestly affects readings; consistent timing useful for trend monitoring. Random measurement is acceptable for screening; diurnal variation is far less than for GH itself.

Where

GP request (often only when GH disorder suspected) or comprehensive private panel.

Typical cost

€30–60 private.

Fasting

Not required

When to test

  • Endocrine Society 2011 (adult GH deficiency)

    Indicated when GH excess (acromegaly) or deficiency is suspected. Routine population screening of healthy adults not recommended.

Where to test

Independent labs offering this test

No direct-to-consumer lab currently in our directory for this marker. Your GP can request it on a standard panel.

Context

Reading the numbers

IGF-1 declines roughly 1–2% per year through adulthood. Very high values may suggest acromegaly; very low values in a symptomatic adult may suggest GH deficiency. Mid-normal-for-age values appear lowest-mortality in most cohort meta-analyses.

Caveats

Acute illness, malnutrition, severe insulin deficiency, and hepatic dysfunction all lower IGF-1 independently of GH-axis status. Oestrogen therapy lowers; testosterone replacement slightly raises.

Practices

What's been shown to influence this marker

Severe protein or energy restriction lowers IGF-1, and adequate protein restores it (Thissen 1994 review); within usual intakes the effect of protein on IGF-1 appears small.

Adequate protein (1.2–1.6 g/kg)CautionHabit
Preliminary evidence

Adequate protein (1.2–1.6 g/kg)

Trials of extra protein show small gains in lean mass in older adults, not clear strength gains. Target used here: 1.2–1.6 g/kg body weight.

Read full evidence

Why

The RDA is 0.8 g/kg. Small trials in older adults are consistent with 1.2 g/kg or more, but do not compare the 1.2–1.6 range against lower intake. Most trials test protein supplements alongside resistance training; one meta-regression found no further fat-free mass gain once total intake passed about 1.6 g/kg/day, with smaller effects at older ages. Distribute across meals.

Slot in your day

With a meal

How to do it

How

Calculate target. Track for a week to see baseline. Add eggs, fish, dairy, legumes, or whey to meals to close the gap.

Sticking with it

Anchor 30g of protein at breakfast. It's the meal most people miss.

Markers this may influence

Caution: Higher protein targets are not advised in chronic kidney disease without specialist advice.

Evidence

At a glance

Wirth 2020 J Nutr meta-analysis (65 RCTs, n=2,907 healthy adults): protein supplementation raised lean body mass by 0.46 kg in older adults, but not handgrip or leg press strength. Morton 2018 Br J Sports Med meta-analysis (49 RCTs, n=1,863) found no further fat-free mass gain from resistance training once total intake passed about 1.6 g/kg/day, with smaller effects at older ages. Trials mostly tested supplements rather than a 1.2-1.6 g/kg target.

GRADE certainty: Low — rated by Healicus using the GRADE method (indirect: trials mostly test protein supplements, largely with resistance training; small effects; strength results inconsistent)

Resistance trainingHabit
Moderate evidence

Resistance training

2 sessions/week, the amount WHO advises from age 65; trials in adults 60+ show gains in muscle mass and strength.

Read full evidence

Why

Sarcopenia (age-related muscle loss) starts in the third decade and accelerates from 50. A network meta-analysis of 151 randomised trials in adults 60+ found resistance training improved lean body mass, muscle size, lower-limb strength and timed walking and mobility tests. WHO advises muscle-strengthening on two or more days a week for adults 65 and over.

Slot in your day

Anytime

How to do it

How

Six compound movements (squat, hinge, push, pull, carry, rotate), 2–3 sets each, 2× per week. Bodyweight is fine to start; progress to weighted as form solidifies.

Ideal for

Adults over 60, where the trials are; younger adults can reasonably start earlier.

Sticking with it

Two fixed weekday slots beat 'three sessions whenever'. The schedule is the programme.

Markers this may influence

Evidence

At a glance

Radaelli 2025 Sports Med systematic review and network meta-analysis (151 RCTs, n=6,306): resistance training in adults 60+ improved lean body mass, muscle size, lower-limb strength and timed function tests. In Villareal 2017 N Engl J Med (RCT, n=160, dieting obese older adults), resistance training limited lean-mass loss to 2%, versus 5% with aerobic training. WHO advises muscle strengthening on two or more days a week from age 65.

GRADE certainty: Moderate — rated by Healicus using the GRADE method

See also

Related markers

Take to your physician

Worth discussing

  • If your value is markedly outside the age-adjusted range, whether further endocrine workup is warranted (GH stimulation testing for low values; pituitary MRI for very high values).
  • Why mid-normal-for-age is the working interpretation in longevity contexts.
  • How to interpret IGF-1 alongside other markers rather than in isolation.

Sources

Cited literature

Last reviewed October 2026

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading